Beauty Health Company (The) - Warrants (04/05/2026) Return on Equity

The latest ROE for SKINW is 240.75%. That is above the Healthcare sector average of 21.3%. Investors often review this figure alongside Beauty Health Company (The) - Warrants (04/05/2026)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SKINW currently prints 240.75% for ROE, while the sector average sits near 21.3%. That is roughly 1030.1% above the sector mean. Large gaps often invite a closer look at Beauty Health Company (The) - Warrants (04/05/2026)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Beauty Health Company (The) - Warrants (04/05/2026) converts resources into returns. At 240.75%, SKINW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SKINW's ROE (240.75%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Beauty Health Company (The) - Warrants (04/05/2026)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.